Nykode Therapeutics AS (VACBF)
OTCMKTS
· Delayed Price · Currency is USD
0.1950
0.00 (0.00%)
At close: Jul 11, 2025
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of $55.96 million as of July 14, 2025. Its market cap has decreased by -87.60% in one year.
Market Cap
55.96M
Enterprise Value
-51.02M
Revenue
8.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.20
Market Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 604.82M to 55.96M, a decrease of -90.75%. That is a compound annual growth rate of -35.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 55.96M | -36.01% |
| Dec 30, 2024 | 87.46M | -87.31% |
| Dec 29, 2023 | 689.14M | -18.07% |
| Dec 30, 2022 | 841.13M | -68.30% |
| Dec 30, 2021 | 2.65B | 6.21% |
| Dec 30, 2020 | 2.50B | 313.01% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.60B |
| Veradigm | 781.22M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 555.99M |
| Glass House Brands | 536.88M |
| CytoDyn | 398.15M |
| American Oncology Network | 378.82M |